The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer
- Conditions
- Metastatic Prostate Cancer
- Interventions
- Drug: [18F]FLOR (FC303) Injection
- First Posted Date
- 2020-08-27
- Last Posted Date
- 2024-01-16
- Target Recruit Count
- 8
- Registration Number
- NCT04528199
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)
- Conditions
- Non-small Cell Lung Cancer (NSCLC)
- Interventions
- Drug: [18F]F-AraG Injection
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2024-01-17
- Target Recruit Count
- 4
- Registration Number
- NCT04524195
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
TheraSphere® For Treatment of Metastases in Liver
- Conditions
- Colorectal CancerColorectal Cancer Metastatic
- Interventions
- Other: Therasphere Therapy
- First Posted Date
- 2020-08-18
- Last Posted Date
- 2023-10-06
- Target Recruit Count
- 4
- Registration Number
- NCT04517643
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study
- Conditions
- Overweight or ObesityBreast Cancer
- Interventions
- Behavioral: Behavioral Weight Loss
- First Posted Date
- 2020-08-05
- Last Posted Date
- 2025-03-06
- Target Recruit Count
- 53
- Registration Number
- NCT04499950
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor
- Conditions
- Nerve Sheath Tumors
- Interventions
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2025-05-08
- Target Recruit Count
- 18
- Registration Number
- NCT04465643
- Locations
- 🇺🇸
Johns Hopkins Medical Institution, Baltimore, Maryland, United States
Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)
- Conditions
- Metastatic Solid TumorU2AF1 Gene MutationSpliceosome MutationSF3B1 Gene MutationSRSF2 Gene Mutation
- Interventions
- Other: Recommendation for treatment with immunotherapy
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2024-08-02
- Target Recruit Count
- 6
- Registration Number
- NCT04447651
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer
- Conditions
- Bladder CancerUrothelial Carcinoma Bladder
- Interventions
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2024-12-20
- Target Recruit Count
- 27
- Registration Number
- NCT04386746
- Locations
- 🇺🇸
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Proton Radiation Therapy Registry
- Conditions
- Cancer, Therapy-Related
- Interventions
- Other: Registry
- First Posted Date
- 2020-05-06
- Last Posted Date
- 2024-06-07
- Target Recruit Count
- 5000
- Registration Number
- NCT04376229
- Locations
- 🇺🇸
Bayview Hospital, Baltimore, Maryland, United States
🇺🇸Suburban Hospital, Washington, District of Columbia, United States
🇺🇸Sibley Memorial Hospital, Washington, District of Columbia, United States
Trial to Promote Recovery From COVID-19 With Endocrine Therapy
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
- Conditions
- Castration Resistant Metastatic Prostate Cancer
- Interventions
- First Posted Date
- 2020-04-27
- Last Posted Date
- 2025-01-06
- Target Recruit Count
- 150
- Registration Number
- NCT04363164
- Locations
- 🇺🇸
Dana-Faber Cancer Institute, Boston, Massachusetts, United States
🇺🇸University of Washington/Fred Hutchinson Cancer Center, Seattle, Washington, United States
🇺🇸University of Nebraska Medical Center, Omaha, Nebraska, United States